On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction.
about
Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunctionClinical use of alprostadil topical cream in patients with erectile dysfunction: a reviewThe devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunctionSolution Structure of the cGMP Binding GAF Domain from Phosphodiesterase 5: INSIGHTS INTO NUCLEOTIDE SPECIFICITY, DIMERIZATION, AND cGMP-DEPENDENT CONFORMATIONAL CHANGETadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.Efficacy of PDE-5-inhibitors for erectile dysfunction. A comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations.Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature.Current treatments and emerging therapeutic approaches in male erectile dysfunction.Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction.Activation and potentiation of the NO/cGMP pathway by NG-hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing.Inflatable penile prosthesis: site-specific malfunction analysis.New achievements and pharmacotherapeutic approaches to impotence in the elderly.Review of tadalafil in the treatment of erectile dysfunction.Emerging oral drugs for erectile dysfunction.Tadalafil pharmacokinetics in healthy subjectsComparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction.Erectile dysfunction: anatomical parameters, etiology, diagnosis, and therapy.Sexual dysfunction after pelvic surgery.The therapeutic dilemma: how to use tadalafil.Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?Molecular and functional characterization of Kv 7 channels in penile arteries and corpus cavernosum of healthy and metabolic syndrome rats.Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic link.Patients' preference in the treatment of erectile dysfunction: a critical review of the literature.Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases.Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double-blind, placebo-controlled trial.Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?Effects of sildenafil on erectile activity in mice lacking neuronal or endothelial nitric oxide synthase.Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED.[How effective are PDE-5 inhibitors?].Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra.Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels.Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.Evaluation of sexual activity in patients treated with tadalafil: a randomized prospective placebo-controlled trial.Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis.Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.
P2860
Q25256846-23A9B5F8-E5D7-43D3-A2FD-70A88A3E32C4Q26740510-7F060AFE-CC71-4FBD-AEF1-0F3EA3329223Q26747680-40C74E2F-1627-4AE6-B060-86141D21B5CAQ27650760-1676B535-270F-4CBC-AAE6-181037FABD52Q30011021-A54C2E77-6EAD-40C1-B41C-83A0943F72C1Q31114948-F6698EFB-6C5C-403F-828B-84C495CF4BFAQ33225656-8BFF6CC6-FDCC-4DE4-ACA6-D554651CB5B6Q33632138-B63D3D35-106C-4552-94CF-0287B100D7B4Q34385721-D286AB2E-D88C-4CD9-B416-5C87109E6B7DQ35038331-DD3A1126-8894-40A1-8E56-3D80B26B89EFQ35044886-DD01C939-AA90-465C-9BA0-D182F8A959E1Q35073153-42AEA608-D972-4317-B43C-BB2524A5144DQ35569842-080FF115-B920-4B45-9040-9F2A2351F51BQ35575000-D6A2A053-28CA-4145-B9E1-A97819BCA2F4Q35779307-69C6CBEF-C271-4339-B059-E2706306AA27Q35827477-D5366DC0-FD42-4107-BED5-31BAA695EC48Q36040691-A9FE01A9-F685-41E0-9BDA-389208D067ADQ36069701-EFBD793F-7CC5-428A-8AD6-80DF995A1EDEQ36179314-46EAF7EC-142A-4DA0-BC3E-3DF8C859DA0BQ36291011-8D93927F-C57D-4E9F-966A-6A07D39C95E6Q36395193-A7223F89-9622-42A2-A08A-05F33BACC3CEQ36689825-7CECB4EC-4DB2-4B21-B939-9A46F89D4B77Q36797402-AB323E1A-A888-4D16-8114-4FBCA42B4CAAQ36836444-B7CC93F5-B917-49AF-A33C-B297EF300D34Q37323310-9708F97B-8444-46B2-AF4C-EFE50E6F9826Q37824592-1B25D94A-0906-4579-8368-BCBA33B1F5A7Q38205932-BCBC3B53-618F-481E-A898-882198463E9EQ38464139-00648DFE-9C57-47DD-92D4-89DA5E2F4F57Q39072124-C7D6BF97-5FF6-488F-9A18-EBE48BA42286Q43263739-7D77EF2D-5909-42F7-A6B0-4B9F2D6EA143Q44257745-530D2B9E-D7B2-45BD-8A57-C2BA9C84EB81Q44327820-642B9CD8-4D5A-4811-8D16-B05033EE2F68Q44417753-16BE38BF-BED1-412B-8930-B8C411EB7648Q44785618-95A481D4-7E14-45DD-B1A3-1B95E3AE44BAQ45050058-8F9898D8-6409-471F-A9C5-5156F6C4C126Q45100354-8B8AE7C9-1DB0-405D-927C-80C40D271F47Q45128188-FF025FAD-B487-485C-B2BE-684ECFEA5035Q48516551-775850E2-16E6-4FBB-B17F-07FA48415246Q53252923-0F68BD64-25B6-4383-A208-EFAECFC1CA31Q55247585-C7810EB1-E206-4B46-B248-0937C5F86042
P2860
On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
On-demand IC351 (Cialis) enhan ...... nts with erectile dysfunction.
@en
On-demand IC351
@nl
type
label
On-demand IC351 (Cialis) enhan ...... nts with erectile dysfunction.
@en
On-demand IC351
@nl
prefLabel
On-demand IC351 (Cialis) enhan ...... nts with erectile dysfunction.
@en
On-demand IC351
@nl
P2093
P356
P1476
On-demand IC351 (Cialis) enhan ...... nts with erectile dysfunction.
@en
P2093
H Padma-Nathan
IC351 On-Demand Dosing Study Group
J G McMurray
J S Whitaker
K M Ferguson
W E Pullman
P2888
P356
10.1038/SJ.IJIR.3900631
P577
2001-02-01T00:00:00Z
P5875
P6179
1003693222